Sign up for regular news, views and insights about corporate governance

Name
Email
Company
Job title
Industry

Close

Setting the benchmark in corporate integrity

Shareholders sue CEO after Walgreens is slapped with $80m DEA fine

The largest drug retailer in the US has hit back at its board members. Chairman James Skinner and CEO Gregory Wasson have been sued by shareholders who blame them for exercising poor corporate oversight regarding the distribution of prescription painkillers like Oxycodone

The mishap resulted in the Drug Enforcement Agency (DEA) levying a fine against Walgreens for $80m. Shareholders believe that the board of directors knowingly breached drug regulations by encouraging the sale of prescription painkillers, which in turn forced the DEA to take out an investigation into Walgreens and the subsequent fine.

The investors who filed the complaint, which consist of a number of small pension funds did so because they are worried the fine will damage the company’s share price. They estimate a four to six percent hit in the third quarter of this year.

“Walgreens admitted, among other things, that it had not upheld its obligations as a DEA registrant, which requires the company to report suspicious orders of prescription painkillers like oxycodone,” according to the complaint.

Walgreens’ top six stores, which are all located in Florida – a state historically known as the American centre of illegal prescription drug sales – were found to be purchasing more than 1.6m dosage purchases of Oxycodone, one of the strongest available painkillers on the market. This is more than 20 times the average amount acquired by other US pharmacies.

“A majority of the board was aware of these improper sales of prescription painkillers since at least 2010 and appears to have either condoned the practices or done nothing to prevent them,” investors told Bloomberg Businessweek.

Kermit Crawford, the president of the pharmacy, health and wellness division for Walgreens, which is headquartered in Deerfield, Illinois explained in a statement “we have worked closely with DEA over the past several months to reach this agreement, which concludes the DEA’s review of out operations.”

The prescription drug epidemic in America continues to be a source of concern, with prescription drug overdoses rising year on year. The Centre for Disease Control and Prevention (CDC) reported that in 2010 that around 12m Americans (age 12 or older) had reported nonmedical use of prescription painkillers in the past year. Drug overdose death rates in the US have more than tripled since 1990. Nonmedical use of prescription painkillers like Oxycodone cost health insurers around $72.5bn annually in direct health care costs.

 

News

EU outlines new disclosure guidelines for extractive industries

Newly introduced laws are to ensure resource-rich nations are less so made subjects of exploitation, requiring for a much greater extent of transparency among extractive industries

Barclay’s share sale to plug capital hole

Barclay’s must raise £12.8bn to cover new regulatory demands

We, the corporations?

Luigi Zingales on the possibility of a mandatory disclosure rule

UK’s FRC rejects calls for compulsory audit rotation

Despite pressure to encourage greater competition in the UK’s accounting market, regulator waters down its proposed rule changes

Ecobank CEO denies charges of fraud citing bank’s strong governance policies

Nigerian Securities and Exchange Commission investigating allegations of fraud in one of Africa’s largest banking institutions

Court rules “unenforceable” arbitration

US courts find arbitration agreements signed by employees are ‘unconscionable’

Community spirit

Research has shown that companies giving back to the communities in which they work tend to enjoy better long-term results

‘Lack of clarity’ in UAE corporate governance

Report raises concerns over listed companies failing to provide clear corporate governance policies

Tech Data delays annual report after regulator questions

US-based technology wholesaler made to delay the publication of its annual report after questions are raised about accounting practices of its UK subsidiary

Legal world “requires categorisation”

As the legal industry continues to boom, it’s becoming ever more challenging for firms to choose where to seek council. Corporate Governance Report spoke to World Finance Editor Alexander Redcliffe about the magazine’s legal awards

Social business collaboration enhances corporate communications

Social media technologies offer unprecedented digital opportunities to share information, communicate and collaborate which are now being translated into a means of internal corporate communication management

Churchill Mining grants 5.4 million share options

Following what many have perceived to be detrimental legal altercations through the past year, the London-listed mining company has since granted new share options to many of its employees

Nigeria to implement corporate governance code by 2014

New code will centralise corporate governance practices and ascribe penalties for lack of compliance

About the awards

The Corporate Governance Report Awards celebrates leaders and innovators in financial reportage, transparency and shareholder relations. We identify those organisations setting the standard in internal …

Carl Icahn gives Apple a boost

Apple’s market value rose by an estimated $17bn after billionaire investor Carl Icahn tweeted his support for the company. Shares have since hit a seven-month high

First IATI annual report published

Initiative outlines both its achievements and intentions for bettering governmental transparency in relation to aid spending in developing nations